Nutrient Gap in ChildrenNCT07893626
A Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in Children
A study testing Hiya Kids Daily Multivitamin in people with Nutrient Gap in Children and Pediatric Health and Well-Being, run by Hiya Health at 1 site in United States.
Trial summary
This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of the Hiya Kids Daily Multivitamin on parent/caregiver-perceived growth and development, immune health, daily energy, focus, and overall well-being in generally healthy children aged 3-12 years over an eight-week… Read more about this study
- Who is it for?
- Ages 3 to 12 yearsHealthy volunteers can take part
- Conditions the study is for
- Nutrient Gap in Children, Pediatric Health and Well-Being, Immune Health
- What is being tested?
- Hiya Kids Daily Multivitamin
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 31 Aug 2026to 26 Oct 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 3 to 12 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Child aged 3-12 years at enrollment.
- Be male or female.
- Parent/caregiver seeking support for a child in at least one of the following areas: difficulties with focus or attention, low or inconsistent daily energy levels, growth and development, or nutrient gaps associated with selective or picky eating.
- Any child who is generally healthy - does not live with any uncontrolled chronic disease.
- Parent or caregiver willing and able to provide written informed consent and obtain age-appropriate assent from their child if the child is 7 years or older.
- Parent or caregiver willing to administer one Hiya Kids Daily Multivitamin chewable tablet once daily, with the first meal of the day, for eight consecutive weeks and complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8.
Show all 10Show fewer
- Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period.
- If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months.
- Child has had a stable diet and sleep schedule for at least four weeks prior to the study.
- Resides in the United States.
Who cannot join
- Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
- Any child who has planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
- Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
- Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
- Any child with any known allergies or hypersensitivities to any supplement product ingredients.
- Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period.
- Any child currently testing, or planning on starting in the next eight weeks, a product for another research study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Citruslabs
Las Vegas, Nevada, 89118
About this study
This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of the Hiya Kids Daily Multivitamin on parent/caregiver-perceived growth and development, immune health, daily energy, focus, and overall well-being in generally healthy children aged 3-12 years over an eight-week supplementation period.
Enrolled children will receive one Hiya Kids Daily Multivitamin chewable tablet administered once daily with the first meal of the day for eight consecutive weeks. Parents or caregivers will complete study-specific questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, and a product acceptability assessment at Week 8. All assessments are completed remotely via the study platform. Forty participants will be enrolled.
- Conditions
- Nutrient Gap in Children, Pediatric Health and Well-Being, Immune Health, Growth and Development, Energy Levels, Focus and Attention
- Being tested
- Hiya Kids Daily Multivitamin
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hiya Kids Daily MultivitaminDietary supplement
Enrolled children will receive one Hiya Kids Daily Multivitamin chewable tablet administered once daily with the first meal of the day for eight consecutive weeks. Parents or caregivers will complete study-specific questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, and a product acceptability assessment at Week 8.
| Study group | Role | What they receive |
|---|---|---|
| Hiya Kids Daily Multivitamin Arm | Experimental | Not described Receives: Dietary Supplement: Hiya Kids Daily Multivitamin |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Parent/Caregiver-Perceived Growth and Development
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Measured: Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent/Caregiver-Perceived Energy
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Measured: Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent/Caregiver-Perceived Focus
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Measured: Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent/Caregiver-Perceived Immune Health
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Measured: Baseline, Week 2, Week 4, Week 6, and Week 8
Change in Parent/Caregiver-Perceived Overall Well-Being
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Measured: Baseline, Week 2, Week 4, Week 6, and Week 8
Secondary outcomes (7)
Parent/Caregiver-Perceived Effect on Growth and Development
Evaluated through caregiver-reported questionnaire assessing perceived product effects
Measured: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Immune Health
Evaluated through caregiver-reported questionnaire including frequency and duration of common illness symptoms
Measured: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Perceived Brain Development
Evaluated through caregiver-reported questionnaire
Measured: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Focus and Attention
Evaluated through caregiver-reported questionnaire
Measured: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Energy Levels
Evaluated through caregiver-reported questionnaire
Measured: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Overall Health and Well-Being
Evaluated through caregiver-reported questionnaire
Measured: Week 2, Week 4, Week 6, and Week 8
Product Acceptability and Ease of Daily Administration
Measured by a caregiver-reported acceptability questionnaire
Measured: Week 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2026
- Study start31 Aug 2026
- Primary completion26 Oct 2026 (estimated)
- Study completion26 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nutrient Gap in ChildrenStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hiya Health
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07893626
- Sponsor's protocol ID
- HIYAH-53438
- Status last verified
- Oct 2026
- First submitted
- 19 Oct 2026
- Last updated
- 26 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in Children
- ClinicalTrials.gov ID
- NCT07893626
- Acronym / sponsor ID
- HIYAH-53438
- Conditions
- Nutrient Gap in Children, Pediatric Health and Well-Being, Immune Health, Growth and Development, Energy Levels, Focus and Attention
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Hiya HealthIndustry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 31 Aug 2026 (actual)
- Primary completion
- 26 Oct 2026 (estimated)
- Study completion
- 26 Oct 2026 (estimated)
- First posted
- 26 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of the Hiya Kids Daily Multivitamin on parent/caregiver-perceived growth and development, immune health, daily energy, focus, and overall well-being in generally healthy children aged 3-12 years over an eight-week supplementation period.
Enrolled children will receive one Hiya Kids Daily Multivitamin chewable tablet administered once daily with the first meal of the day for eight consecutive weeks. Parents or caregivers will complete study-specific questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, and a product acceptability assessment at Week 8. All assessments are completed remotely via the study platform. Forty participants will be enrolled.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Hiya Kids Daily Multivitamin Arm | Experimental | Dietary Supplement: Hiya Kids Daily Multivitamin |
Who may qualify
- Ages
- 3 to 12 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (10 listed)
- Child aged 3-12 years at enrollment.
- Be male or female.
- Parent/caregiver seeking support for a child in at least one of the following areas: difficulties with focus or attention, low or inconsistent daily energy levels, growth and development, or nutrient gaps associated with selective or picky eating.
- Any child who is generally healthy - does not live with any uncontrolled chronic disease.
- Parent or caregiver willing and able to provide written informed consent and obtain age-appropriate assent from their child if the child is 7 years or older.
Key exclusion criteria (7 listed)
- Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
- Any child who has planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
- Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
- Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
- Any child with any known allergies or hypersensitivities to any supplement product ingredients.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hiya Kids Daily MultivitaminEnrolled children will receive one Hiya Kids Daily Multivitamin chewable tablet administered once daily with the first meal of the day for eight consecutive weeks. Parents or caregivers will complete study-specific questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8, and a product acceptability assessment at Week 8. | Dietary supplement | Hiya Kids Daily Multivitamin Arm |
Primary outcome
Change in Parent/Caregiver-Perceived Growth and Development
Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Change in Parent/Caregiver-Perceived Energy
Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Change in Parent/Caregiver-Perceived Focus
Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Change in Parent/Caregiver-Perceived Immune Health
Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Change from Baseline assessed via study-specific caregiver-reported questionnaire
Change in Parent/Caregiver-Perceived Overall Well-Being
Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8
Change from Baseline assessed via study-specific caregiver-reported questionnaire
7 secondary outcomes
Parent/Caregiver-Perceived Effect on Growth and Development
Time frame: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Immune Health
Time frame: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Perceived Brain Development
Time frame: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Focus and Attention
Time frame: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Energy Levels
Time frame: Week 2, Week 4, Week 6, and Week 8
Parent/Caregiver-Perceived Effect on Overall Health and Well-Being
Time frame: Week 2, Week 4, Week 6, and Week 8
Product Acceptability and Ease of Daily Administration
Time frame: Week 8
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hiya Kids Daily Multivitamin in people with Nutrient Gap in Children and Pediatric Health and Well-Being, run by Hiya Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Patrick Renner (42424250284, hello@citruslabs.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Parent/Caregiver-Perceived Growth and Development (time frame: Baseline, Week 2, Week 4, Week 6, and Week 8). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026; AzTrials last refreshed its copy on 7 Nov 2026.